Oncology Biotech developing first-in-class antibodies, ADCs and bispecifics to conquer life-threatening cancers and unmet needs such as AML, MDS, CTCL and FL.
Oncology Biotech developing first-in-class antibodies, ADCs and bispecifics to conquer life-threatening cancers and unmet needs such as AML, MDS, CTCL and FL.